Association between in situ steroids and spine surgical site infections among instrumented procedures
Infection Control & Hospital Epidemiology · 2023-10 · 44 (10) · 1596-1600
DOI: 10.1017/ice.2023.28 ↗Kurz gefasst
Fachartikel in der Zeitschrift Infection Control & Hospital Epidemiology, online erschienen am 08.03.2023. Verfasst von James E Lee und 5 weiteren Autor:innen. Beteiligte Einrichtung: Section of Neurosurgery, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire. Hauptthemen laut MEDLINE: Surgical Wound Infection, Spinal Fusion. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 21 Literaturangaben.
Abstract (Originalsprache)
Objective
To estimate the association between in situ steroids and spine surgical-site infections (SSIs), assessing spinal instrumentation as an effect modifier and adjusting for confounders.
Design
Case–control study.
Setting
Rural academic medical center.
Participants
We identified 1,058 adults undergoing posterior fusion and laminectomy procedures as defined by the National Healthcare Safety Network without a pre-existing SSI between January 2020 and December 2021. We identified 26 SSI as cases and randomly selected 104 controls from the remaining patients without SSI.
Methods
The primary exposure was the intraoperative administration of methylprednisolone in situ (ie, either in the wound bed or as an epidural injection). The primary outcome was a clinical diagnosis of SSI within 6 months of a patient’s first spine surgery at our facility. We quantified the association between the exposure and outcome using logistic regression, using a product term to assess for effect modification by spinal instrumentation and the change-in-estimate approach to select significant confounders.
Results
Adjusting for Charlson comorbidity index and malignancy, in situ steroids were significantly associated with spine SSI relative to no in situ steroids for instrumented procedures (adjusted odds ratio [aOR], 9.93; 95% confidence interval [CI], 1.54–64.0), but they were not associated with spine SSIs among noninstrumented procedures (aOR, 0.86; 95% CI, 0.15–4.93).
Conclusions
In situ steroids were significantly associated with spine SSI among instrumented procedures. The benefits of in situ steroids for pain management following spine surgery should be weighed against the risk of SSI, especially for instrumented procedures.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Section of Neurosurgery, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire.
- Collaborative Healthcare-associated Infection Prevention Program, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire.
- Quality Assurance and Safety, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire.
- Quality Assurance and Safety, Dartmouth Health, Lebanon, New Hampshire.
- Section of Infectious Disease and International Health, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire.
ORCID-Profile: Justin J Kim
Zitieren
APA
Lee, J. E., Stewart, K. O., Swain, J. L., Bond, E., Calderwood, M. S., & Kim, J. J. (2023). Association between in situ steroids and spine surgical site infections among instrumented procedures. Infection Control & Hospital Epidemiology, 44(10), 1596-1600. https://doi.org/10.1017/ice.2023.28
Vancouver
Lee JE, Stewart KO, Swain JL, Bond E, Calderwood MS, Kim JJ. Association between in situ steroids and spine surgical site infections among instrumented procedures. Infection Control & Hospital Epidemiology. 2023;44(10):1596-1600. doi:10.1017/ice.2023.28
BibTeX
@article{Lee2023,
author = {Lee, James E and Stewart, Kathleen O and Swain, Jessica L and Bond, Evalina and Calderwood, Michael S and Kim, Justin J},
title = {Association between in situ steroids and spine surgical site infections among instrumented procedures},
journal = {Infection Control & Hospital Epidemiology},
year = {2023},
volume = {44},
number = {10},
pages = {1596--1600},
doi = {10.1017/ice.2023.28}
}
EUVIMED